Barclays
MESO

Barclays’s Mesoblast MESO Stock Holding History

Barclays’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.7K Buy
1,282
+102
+9% +$1.7K ﹤0.01% 4579
2025
Q4 		$21.3K Buy
1,180
+639
+118% +$11K ﹤0.01% 4865
2025
Q3 		$8.71K Sell
541
-3,030
-85% -$44.3K ﹤0.01% 5032
2025
Q2 		$38.9K Buy
3,571
+1,014
+40% +$11.4K ﹤0.01% 4742
2025
Q1 		$31.9K Buy
2,557
+657
+35% +$10.8K ﹤0.01% 4707
2024
Q4 		$37.6K Buy
+1,900
New +$21K ﹤0.01% 4819
2021
Q4 		– Sell
-19
Closed – – 4514
2021
Q3 		$0 Sell
19
-6,481
-100% -$90K ﹤0.01% 4901
2021
Q2 		$97K Buy
6,500
+6,050
+1,344% +$95K ﹤0.01% 3852
2021
Q1 		$7K Sell
450
-500
-53% -$9.45K ﹤0.01% 4466
2020
Q4 		$16K Sell
950
-5,000
-84% -$123K ﹤0.01% 4700
2020
Q3 		$221K Buy
5,950
+5,500
+1,222% +$172K ﹤0.01% 3785
2020
Q2 		$10K Buy
+450
New +$9.63K ﹤0.01% 5324
2019
Q1 		– Sell
-76
Closed -$1K – 7199
2018
Q4 		$1K Buy
+76
New +$871 ﹤0.01% 6814

Other funds holding MESO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Barclays's MESO Position: Q1 2026 in Review

Barclays increased its Mesoblast (MESO) stake by 8.6% in Q1 2026, buying an estimated $1.7K and bringing the position to 1,282 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4579.

Barclays first reported a position in MESO in Q4 2018 and has held it in 13 quarters since. The position peaked at $221K in Q3 2020. 69 funds tracked by Wall St. Rank hold MESO as of Q1 2026.

  • Barclays held 1,282 shares of Mesoblast worth $19.7K as of Q1 2026.
  • Barclays bought 102 Mesoblast shares in Q1 2026, an estimated $1.7K.
  • Mesoblast made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4579 holding.
  • Barclays first reported a position in Mesoblast in Q4 2018 and has held it in 13 quarters since.
  • Barclays's Mesoblast position peaked at $221K in Q3 2020.
  • 69 funds tracked by Wall St. Rank held Mesoblast as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.